Pangenomic Health Inc. (NARA.CN) Research

Pangenomic Health Inc., a precision health enterprise, develops a digital self-care platform designed to deliver personalized, scientifically-backed information on natural treatments for mental well-being. This platform includes the Nara App, a mobile application for consumers that offers a knowledge base tailored to individual user profiles. Additionally, the company provides the PlantGx Platform, a digital therapeutics solution for clinics, enabling healthcare professionals to access patient health data (with patient authorization) originating from the Nara App and facilitating patient referrals. The firm, established in 2015, previously operated as Zetta Capital Corp. before rebranding to PanGenomic Health Inc. in December 2021. Its headquarters are located in Vancouver, Canada.

Market snapshot

Symbol
NARA.CN
Price
$0.32
Day change
-3.03%
Market cap
$4.5M
P/E ratio
-2.07x
52-week range
0.29-2.57
Sector
Healthcare
Industry
Medical - Healthcare Information Services

Peer companies

  • AI/ML Innovations Inc. (AIML.CN)
  • Britannia Life Sciences Inc. (BLAB.CN)
  • Comprehensive Healthcare Systems, Inc. (CHS.V)
  • Rapid Dose Therapeutics Corp. (DOSE.CN)
  • Hemostemix Inc. (HEM.V)
  • PreveCeutical Medical Inc. (PREV.CN)
  • Red White & Bloom Brands Inc. (RWB.CN)
  • Red Light Holland Corp. (TRIP.CN)

Open Pangenomic Health Inc. (NARA.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.